The Ozempic Effect: How the Weight-Loss Boom Triggered a Public Health Crisis
In the landscape of modern medicine, few pharmaceutical advancements have captured the public imagination—and the global market—quite like the rise of Glucagon-Like Peptide-1 Receptor Agonists (GLP-1RAs). Drugs like semaglutide, marketed under the brand…
The Big Short 2.0: Michael Burry Targets Caterpillar in a High-Stakes Bet Against the AI Infrastructure Boom
By Financial Correspondent In the volatile landscape of modern finance, few names carry as much weight—or spark as much controversy—as Michael Burry. The hedge fund manager, immortalized in Michael Lewis’s The Big Short for his clairvoyant and highly…